Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
49
RMTI Quote, Financials, Valuation and Earnings
Last price:
$1.01
Seasonality move
:
14.03%
Day range:
$0.97 - $1.02
52-week range:
$0.78 - $2.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.46x
P/B ratio:
1.09x
Volume:
165.3K
Avg. volume:
337.6K
1-year change:
-54.26%
Market cap:
$40.2M
Revenue:
$101.5M
EPS (TTM):
-$0.16
Analysts' Opinion
-
Consensus RatingRockwell Medical, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $3.75, Rockwell Medical, Inc. has an estimated upside of 267.65% from its current price of $1.02.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.50 representing 100% downside risk from its current price of $1.02.
Fair Value
-
According to the consensus of 1 analyst, Rockwell Medical, Inc. has 267.65% upside to fair value with a price target of $3.75 per share.
RMTI vs. S&P 500
-
Over the past 5 trading days, Rockwell Medical, Inc. has overperformed the S&P 500 by 6.25% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Rockwell Medical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Rockwell Medical, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Rockwell Medical, Inc. reported revenues of $15.9M.
Earnings Growth
-
Rockwell Medical, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Rockwell Medical, Inc. reported earnings per share of -$0.05.
Enterprise value:
29.6M
EV / Invested capital:
0.59x
Price / LTM sales:
0.46x
EV / EBIT:
29.39x
EV / Revenue:
0.39x
PEG ratio (5yr expected):
-0.04x
EV / Free cash flow:
-10.09x
Price / Operating cash flow:
11.90x
Enterprise value / EBITDA:
31.81x
Gross Profit (TTM):
$11.4M
Return On Assets:
-9.84%
Net Income Margin (TTM):
-7.3%
Return On Equity:
-17.16%
Return On Invested Capital:
-12.07%
Operating Margin:
-9.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $80.8M | $98.9M | $75.6M | $28.3M | $15.9M | |
| Gross Profit | $8.2M | $16.7M | $11.4M | $6.2M | $2.3M | |
| Operating Income | -$8.1M | $580K | -$4.8M | $1.9M | -$1.6M | |
| EBITDA | -$5.5M | $2.8M | -$2.6M | $2.5M | -$1M | |
| Diluted EPS | -$0.55 | -$0.06 | -$0.16 | $0.04 | -$0.05 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $46.1M | $42.4M | $28.2M | $34.2M | $37.5M | |
| Total Assets | $58.7M | $54.2M | $52.6M | $57.1M | $57.5M | |
| Current Liabilities | $21.8M | $19.3M | $21.4M | $14.2M | $9.6M | |
| Total Liabilities | $47.6M | $38.1M | $31.1M | $27.9M | $20.5M | |
| Total Equity | $11.1M | $16.1M | $21.5M | $29.1M | $37M | |
| Total Debt | $26.5M | $19.4M | $12.9M | $12.2M | $11.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$10M | $3.3M | -$2.1M | $4.3M | -$1.3M | |
| Cash From Investing | -$1.8M | -$2.5M | -$4.7M | -$6.1M | -$4.3M | |
| Cash From Financing | $6.6M | $3.8M | $8.1M | $2.3M | $6.7M | |
| Free Cash Flow | -$22.6M | $2.6M | -$2.9M | $4.1M | -$1.5M | |
RMTI
Sector
Market Cap
$40.2M
$28.4M
Price % of 52-Week High
42.32%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-24.01%
-1.32%
1-Year Price Total Return
-54.26%
-22.19%
Beta (5-Year)
1.621
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.96
200-day SMA
Sell
Level
$1.17
Bollinger Bands (100)
Sell
Level
0.93 - 1.41
Chaikin Money Flow
Sell
Level
-59.4M
20-day SMA
Buy
Level
$0.95
Relative Strength Index (RSI14)
Buy
Level
52.95
ADX Line
Buy
Level
17.41
Williams %R
Sell
Level
-5.211
50-day SMA
Sell
Level
$1.08
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.6245)
Buy
CA Score
(Annual)
Level (0.2258)
Buy
Beneish M-Score
(Annual)
Level (-3.2666)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (9.5266)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
Stock Forecast FAQ
In the current month, RMTI has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RMTI average analyst price target in the past 3 months is $3.75.
-
Where Will Rockwell Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Rockwell Medical, Inc. share price will rise to $3.75 per share over the next 12 months.
-
What Do Analysts Say About Rockwell Medical, Inc.?
Analysts are divided on their view about Rockwell Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Rockwell Medical, Inc. is a Sell and believe this share price will drop from its current level to $2.50.
-
What Is Rockwell Medical, Inc.'s Price Target?
The price target for Rockwell Medical, Inc. over the next 1-year time period is forecast to be $3.75 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RMTI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Rockwell Medical, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of RMTI?
You can purchase shares of Rockwell Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Rockwell Medical, Inc. shares.
-
What Is The Rockwell Medical, Inc. Share Price Today?
Rockwell Medical, Inc. was last trading at $1.01 per share. This represents the most recent stock quote for Rockwell Medical, Inc.. Yesterday, Rockwell Medical, Inc. closed at $1.02 per share.
-
How To Buy Rockwell Medical, Inc. Stock Online?
In order to purchase Rockwell Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get RMTI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RMTI
Sector
P/E ratio
--
23.66x
PEG ratio
-0.04x
-0.01x
P/B ratio
1.09x
1.84x
Price / LTM sales
0.46x
1.60x
Growth Metrics
RMTI
Sector
Revenue growth
-43.75%
4.85%
Earnings growth
-210.43%
11.15%
Revenue (5-year growth)
10.61%
6.45%
Earnings forecast
$0.01
-$0.20
Profitability
RMTI
Sector
Profitability FY 2024
$17.5M
$3.6M
Return on invested capital
-12.07%
-30.98%
Return on assets
-9.84%
-27.62%
Return on equity
-17.16%
-36.69%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
26
Estimated Next Earnings Date
Feb
11
Balance Sheet
RMTI
Sector
Total cash
$23.7M
$27.2M
Short term investments
$5.9M
$25.7M
Total assets
$59.2M
$79.9M
Long term debt
$11.3M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
44
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
